ORM2 and breast carcinoma: Among the four biomarker candidates, ORM2 showed significant up-regulation in both biopsied and LCM breast cancer tissues relative to normal controls (p < 0.001), whose log2-transformed fold changes (log2FC) in the medians were 0.88 and 1.09, respectively (Figure 3).